Identification of HLA-A*0201-restricted cytotoxic T lymphocyte epitope from proliferating cell nuclear antigen

By Xu Wei  

Tumor Biology, Vol. 32, Iss. 1, 2011-02 ,pp. : 63-69

Springer Publishing Company

Access to resources Recommend Favorite

Identification of a new HLA-A*0201-restricted cytotoxic T lymphocyte epitope from CML28

By Han Jun-Feng   Zhao Ting-Ting   Liu Hong-Li   Lin Zhi-Hua   Wang Hui-Ming   Ruan Zhi-Hua   Zou Li-Yun   Wu Yu-Zhang  

Cancer Immunology, Immunotherapy, Vol. 55, Iss. 12, 2006-12 ,pp. : 1575-1583

Springer Publishing Company

Access to resources Recommend Favorite

Analysis of cytotoxic T lymphocytes from a patient with hepatocellular carcinoma who showed a clinical response to vaccination with a glypican3derived peptide

By                

International Journal of Oncology, Vol. 43, Iss. 4, 2013-01 ,pp. : 1019-1026

Spandidos Publications

Access to resources Recommend Favorite

Identification of a new hTERT-derived HLA-A*0201 restricted, naturally processed CTL epitope

By Thorn Mette   Wang Mingjun   Kløverpris Henrik   Schmidt Esben   Fomsgaard Anders   Wenandy Lynn   Berntsen Annika   Brunak Søren   Buus Søren   Claesson Mogens  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 11, 2007-11 ,pp. : 1755-1763

Springer Publishing Company

Access to resources Recommend Favorite

The cytotoxic T cell response to peptide analogs of the HLA-A*0201-restricted MUC1 signal sequence epitope, M1.2

By Mitchell Malcolm   Lund Teri   Sewell Andrew   Marincola Francesco   Paul Elyse   Schroder Kim   Wilson Darcy   Kan-Mitchell June  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 3, 2007-03 ,pp. : 287-301

Springer Publishing Company

Access to resources Recommend Favorite